Financing History
| Measure | Date | Issue volume | Issueprice | Volume | Prospectus |
|---|---|---|---|---|---|
|
Rights issue using authorised capital |
02.09.2022 |
12,408,648 new shares |
EUR 6.44 |
EUR 80.0 Mio. | |
|
BCash capital increase of around 10% using authorised capital (private placement excluding shareholders’ subscription rights)
|
15.6.2021
|
3,106,637 new shares |
EUR 6.44 |
EUR 20.0 Mio. | |
|
Cash capital increase of around 10% using authorised capital (private placement excluding shareholders’ subscription rights) |
27.4.2020 |
2,820,961 new shares |
EUR 5.10 |
EUR 14.4 Mio. | |
|
Capital measure consisting of capital increase from authorized capital and from issue of convertible bonds |
22.11.2017 |
7,484,190 new shares |
EUR 2.60 |
EUR 34.4 Mio. | |
|
Rights issue using authorised capital |
15.5.2017 |
2,040,816 new shares |
EUR 2.45 |
EUR 4.99 Mio. | |
|
Rights issue using authorised capital |
25.4.2016 |
2,248,272 new shares |
EUR 1.84 |
EUR 4.13 Mio. | |
|
Rights issue using authorised capital |
9.12.2015 |
443,124 new shares |
EUR 1.84 |
EUR 0.8 Mio. | |
|
Cash capital increase of around 10% using authorised capital completed with dievini (private placement excluding shareholders’ subscription rights) |
9.12.2015 |
930,560 new shares |
EUR 1.84 |
EUR 1.7 Mio. | |
|
Rights issue using authorised capital |
13.4.2015 |
1,486,732 new shares |
EUR 2.80 |
EUR 4.16 Mio. | |
|
Ordinary share capital reduction through the consolidation of shares |
18.7.2014 | ||||
|
Combined capital increase of cash and contribution in kind (Rights offering and private placement) |
27.9.2012 |
up to 6,460,544 new shares |
EUR 3.70 |
EUR 16.1 million in cash | |
|
Rights issue
|
3.2.2012
|
3,201,928 new shares |
EUR 3.10 |
EUR 9.9 Mio. |